Transcept Pharmaceuticals, Inc. (TSPT) Finishes Patient Enrollment in Phase 2 Trial of TO-2061
Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic…